Skip to content
OpenCapital
Get started

Unicycive Therapeutics, Inc. UNCY Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.39Beat by $0.20
EPS estimate-$0.59

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$22.2M
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q1 2026-$0.54Miss by $0.08Q4 2025-$0.32Beat by $0.19
Q3 2025-$0.39Beat by $0.20
Q2 2025-$0.52Beat by $0.18Q1 2025-$0.26Miss by $0.13Q4 2024-$0.16Miss by $0.03

Ask the moment Unicycive Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Unicycive Therapeutics, Inc. report Q3 2025 earnings?
Unicycive Therapeutics, Inc. (UNCY) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Unicycive Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Unicycive Therapeutics, Inc. reported eps of $-0.39 for Q3 2025.
Did Unicycive Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.59 by $0.20.
Where can I find Unicycive Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-108847) and the 10-Q periodic report (0001213900-25-108600) directly on SEC EDGAR. The filing index links above go to sec.gov.